CEPI Focus Area 2: Vaccine Candidates for Priority Pathogens and Viral Families
Funds organizations conducting preclinical vaccine development for CEPI priority pathogens and Disease X exemplars through CEPI's Innovations call.
CEPI (Coalition for Epidemic Preparedness Innovations), a non-profit international association headquartered in Oslo, administers this grant under its Innovations to Prepare for Future Epidemics and Pandemics call — specifically Focus Area 2, which targets vaccine candidates for priority pathogens and viral families. Awards of up to US $5 million fund preclinical proof-of-concept work, including I…
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.
Funds organizations conducting clinical trials of vaccine candidates against CEPI priority pathogens and viral families through CEPI's Innovations Call for Proposals.
Funds organizations designing and early-stage testing of new vaccine candidates against CEPI priority pathogens and Disease X viral families, with awards up to $1M over 18 months.
Funds organizations conducting preclinical vaccine development for CEPI priority pathogens and Disease X exemplars through CEPI's Innovations call.